What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

Eli Lilly bowel disease treatment succeeds in late-stage study

Eli Lilly and Co said on Tuesday its experimental treatment for an inflammatory bowel disease succeeded in a late-stage trial.

EU says Pfizer to deliver over 200 million vaccine doses in second quarter

The European Commission expects to receive more than 200 million doses of COVID-19 vaccine from Pfizer and BioNTech in the second quarter, it said on Tuesday, putting the European Union on course to meet its inoculation target.

WHO vaccine safety panel may issue statement on AstraZeneca on Tuesday - spokesman

A World Health Organization (WHO) panel of experts examining data on Tuesday from use of the AstraZeneca COVID-19 vaccine may issue a statement at the end of the day, a WHO spokesman said.

Canada's Medicago begins late-stage study of COVID-19 vaccine

Canadian drug developer Medicago said on Tuesday it had started a late-stage study of its experimental COVID-19 vaccine combined with a booster from GlaxoSmithKline.

Moderna begins study of COVID-19 vaccine in kids

Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday.

India's Gland Pharma to make up to 252 million Sputnik V vaccine doses

Gland Pharma Ltd said on Tuesday it had struck a deal with the Russian Direct Investment Fund (RDIF) to make up to 252 million doses of the Sputnik V COVID-19 vaccine, bringing India's total production of the shot to at least 352 million.

Kremlin says pressure on countries to reject Russia's Sputnik V vaccine is unprecedented

The Kremlin said on Tuesday that pressure on some countries to refuse to buy Russia's Sputnik V vaccine against COVID-19 was at unprecedented levels but had no chance of succeeding.

France seeks quick resumption of AstraZeneca shots suspended over safety fears

France expressed hope European medical experts would clear up questions over the safety of AstraZeneca's COVID-19 shot on Thursday, as experts warned the decision by major European states to stop using it posed a greater risk to public health.

French Industry Minister: AstraZeneca CEO is 'on a hot seat'

The chief executive of AstraZeneca - whose COVID-19 vaccine has been temporarily suspended in several European countries - is "on a hot seat and knows it", said French Industry Minister Agnes Pannier-Runacher.

Russia identifies two cases of South African COVID-19 variant, says regulator

Russia has identified two cases of the new variant of the coronavirus first detected in South Africa, consumer health regulator Rospotrebnadzor said in a statement on Tuesday.

Related Videos

Americans say: No vaccine? No flight -poll

Pfizer to exceed vaccine production target by 20%